N/A N=591 Randomized Double-blind Supportive Care

Alcon Multi-Purpose Disinfecting Solution Versus Renu Fresh Multi-Purpose Solution in Symptomatic Contact Lens Wearers

Symptomatic Contact Lens Wearers

Bottom Line

View on ClinicalTrials.gov: NCT01187355 ↗

Enrolled (actual)

591

Serious AEs

0.3%

Results posted

Jul 2012

Primary outcome: Primary: Likert Statement: When I Use This Solution, I Can Comfortably Wear my Lenses. — 3.9; 3.8 Units on a scale

Study Design & Population

Study type: Interventional
Phase: N/A
Interventions: FID 114675A Multi-Purpose Disinfecting Solution (MPDS) (Device); renu fresh Multi-Purpose Solution (MPS) (Device); Contact lenses (Device)
Age: Adult, Older Adult · 18+ yrs
Sex: All
Sponsor: Alcon Research
Primary completion: Jan 2011

Outcome Measures

Outcome	Result	p-value
PRIMARY Likert Statement: When I Use This Solution, I Can Comfortably Wear my Lenses.	3.9; 3.8	—
SECONDARY Likert Statement: When I Use This Solution, My Lenses Are Comfortable From Morning Until Evening.	3.3; 3.2	—
SECONDARY Likert Statement: When I Use This Solution, I Forget I am Wearing my Lenses.	3.2; 3.1	—

Summary

The purpose of this study is to compare two contact lens care solutions in symptomatic wearers of silicone hydrogel contact lenses.

Eligibility Criteria

Inclusion Criteria

Symptomatic silicone hydrogel contact lens wearers who wear their lenses daily wear (i.e., disinfect lenses every night).
Vision correctable to 20/30 or better with contact lenses.
Other protocol-defined inclusion criteria may apply.

Exclusion Criteria

Sensitivity to multi-purpose solutions.
Use of any topical ocular OTC or prescribed topical ocular medications.
History (6 months) or current ocular infections or ocular inflammatory events.
Ocular surgery within the past year.
Medical condition or use of medications that cause ocular side effects.
Participation in any investigational study within the past 30 days.
Other protocol-defined exclusion criteria may apply.

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT01187355). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.